A nonlinear relationship between cerebral serotonin transporter and 5HT-2A receptor binding: An in vivo molecular imaging study in humans

Journal of Neuroscience

Volumn 30, Issue 9, 2010, Pages 3391-3397

  Erritzoe, David ^a,b   Holst, Klaus ^b,c   Frokjaer, Vibe G ^a,b   Licht, Cecilie L ^a,b   Kalbitzer, Jan ^a,b   Nielsen, Finn Å ^b,d   Svarer, Claus ^a,b   Madsen, Jacob ^a   Knudsen, Gitte ^a,b  

^a Rigshospitalet   (Denmark)

^b Center for Integrated Molecular Brain Imaging   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL)BENZONITRILE C 11; ALTANSERIN F 18; RADIOLIGAND; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN LEVEL; BRAIN REGION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOLECULAR IMAGING; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; RAPHE NUCLEUS; RECEPTOR BINDING;

ADULT; AGED; AGED, 80 AND OVER; BENZYLAMINES; BINDING, COMPETITIVE; BRAIN CHEMISTRY; BRAIN MAPPING; CEREBRAL CORTEX; COMPUTER SIMULATION; FEMALE; HUMANS; KETANSERIN; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION; YOUNG ADULT;

EID: 77749324823     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2852-09.2010     Document Type: Article

References (74)

1. 2A receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage 21:1105-1113.
2. Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, Bolwig TG, Knudsen GM (2005) Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 8:391- 401.
3. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A,Mössner R, Westphal H, Lesch KP (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53:649-655.
4. Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG, Frazer A (1999) Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 19:10494 -10501.
5. Benmansour S, Owens WA, Cecchi M, Morilak DA, Frazer A (2002) Serotonin clearance in vivo is altered to a greater extent by antidepressantinduced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22:6766-6772.
6. Blakely RD, De Felice LJ, Hartzell HC (1994) Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196:263-281.
7. Blue ME, Yagaloff KA, Mamounas LA, Hartig PR, Molliver ME (1988) Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex. Brain Res 453:315-328.
8. Boothman LJ, Allers KA, Rasmussen K, Sharp T (2003) Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. Br J Pharmacol 139:998 -1004.
9. Cahir M, Ardis T, Reynolds GP, Cooper SJ (2007) Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology (Berl) 190:497-506.
10. 3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology 32:737-743.
11. 3H]paroxetine. Neuroscience 27:473- 496.
12. Cowen PJ (1990) A role for 5-HT in the action of antidepressant drugs. Pharmacol Ther 46:43-51.
13. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE (1994) Performance characteristics of a whole-body PET scanner. J Nucl Med 35:1398 -1406.
14. 3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment. J Neurochem 58:250 -257.
15. Erritzoe D, Frokjaer VG, Haugbol S, Marner L, Svarer C, Holst K, Baaré WF, Rasmussen PM, Madsen J, Paulson OB, Knudsen GM (2009) Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage 46:23-30.
16. Evrard A, Malagié I, Laporte AM, Boni C, Hanoun N, Trillat AC, Seif I, De Maeyer E, Gardier A, Hamon M, Adrien J (2002) Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. Eur J Neurosci 15:841- 851.
17. Frokjaer VG, Vinberg M, Erritzoe D, Svarer C, Baaré W, Budtz-Joergensen E, Madsen K, Madsen J, Kessing LV, Knudsen GM (2009) High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding. Neuroimage 46:360 -366.
18. Gobbi M, Crespi D, Foddi MC, Fracasso C, Mancini L, Parotti L, Mennini T (1997) Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn Schmiedebergs Arch Pharmacol 356:22-28.
19. Gould GG, Pardon MC, Morilak DA, Frazer A (2003) Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems. Neuropsychopharmacology 28:1633-1641.
20. Gould GG, Altamirano AV, Javors MA, Frazer A (2006) A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol Psychiatry 59:408-414.
21. 3H]paroxetine binding to cerebral cortical membranes of the rat. Neuropharmacology 26:1087-1092.
22. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83- 87.
23. Günther L, Liebscher S, Jähkel M, Oehler J (2008) Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice. Eur J Pharmacol 593:49-61.
24. HaugbØl S, Pinborg LH, Regeur L, Hansen ES, Bolwig TG, Nielsen FA, Svarer C, Skovgaard LT, KnudsenGM (2007) Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. Int J Neuropsychopharmacol 10:245-252.
25. Heal DJ, Philpot J, Molyneux SG, Metz A (1985) Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both headtwitch response and the number of cortical 5-HT2 receptors. Neuropharmacology 24:1201-1205.
26. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, Linnoila M, Weinberger DR (2000) A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 47:643- 649.
27. Horschitz S, Hummerich R, Schloss P (2001) Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor. Neuroreport 12:2181-2184.
28. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096 -1112.
29. Jennings KA, Sheward WJ, Harmar AJ, Sharp T (2008) Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function. Neuropharmacology 54:776 -783.
30. Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R, Kennedy D, Schmitt F, Brown G, Macfall J, Fischl B, Dale A (2006) Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 30:436-443.
31. Kish SJ, Furukawa Y, Chang LJ, Tong J, Ginovart N, Wilson A, Houle S, Meyer JH (2005) Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl Med Biol 32:123-128.
32. Kovachich GB, Aronson CE, Brunswick DJ (1992) Effect of repeated administration of antidepressants on serotonin uptake sites in limbic and neocortical structures of rat brain determined by quantitative autoradiography. Neuropsychopharmacology 7:317-324.
33. Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L (1995) Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 352:141-148.
34. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Müller CR, Hamer DH, Murphy DL (1996) Association of anxietyrelated traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
35. Licht CL, Marcussen AB, Wegener G, Overstreet DH, Aznar S, Knudsen GM (2009) The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J Neurochem 109:1363-1374.
36. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH (1998) Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155:207-213.
37. Lowry CA (2002) Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol 14:911-923.
38. Lundberg J, Borg J, Halldin C, Farde L (2007) A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain. Psychopharmacology (Berl) 195:425- 433.
39. Maj J, Bijak M, Dziedzicka-Wasylewska M, Rogoz R, Rogoz Z, Skuza G, Tokarski T (1996) The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain. Psychopharmacology (Berl) 127:73- 82.
40. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V (2000) A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729 -738.
41. 18F]-altanserin PET study. Eur J Nucl Med Mol Imaging 36:287-293.
42. Meyer JH (2007) Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 32:86 -102.
43. 18F]setoperone PET imaging study. Am J Psychiatry 158:78-85.
44. Miner LA, Backstrom JR, Sanders-Bush E, Sesack SR (2003) Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 116:107-117.
45. Morilak DA, Somogyi P, Lujan-Miras R, Ciaranello RD (1994) Neurons expressing 5-HT2 receptors in the rat brain: neurochemical identification of cell types by immunocytochemistry. Neuropsychopharmacology 11:157-166.
46. Murdoch DJ, Chow ED (1996) A graphical display of large correlation matrices. Am Stat 50:178 -180.
47. Nelson DR, Thomas DR, Johnson AM (1989) Pharmacological effects of paroxetine after repeated administration to animals. Acta Psychiatr Scand Suppl 350:21-23.
48. Parsey RV, Hastings RS, Oquendo MA, Hu X, Goldman D, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ (2006) Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 163:48-51.
49. Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain-IV. Autoradiography mapping of serotonin-2 receptors. Neuro-science 21:123-139.
50. 18F]altanserin-PET and the bolus/infusion approach. J Cereb Blood Flow Metab 23:985-996.
51. 18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. J Cereb Blood Flow Metab 24:1037-1045.
52. Piñeyro G, Blier P, Dennis T, de Montigny C (1994) Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14:3036 -3047.
53. 18F] MPPF positron emission tomography study. Biol Psychiatry 56:587-591.
54. Praschak-Rieder N, Wilson AA, Hussey D, Carella A, Wei C, Ginovart N, Schwarz MJ, Zach J, Houle S, Meyer JH (2005) Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol Psychiatry 58:825- 830.
55. 11C] DASB positron emission tomography study. Biol Psychiatry 62:327-331.
56. 3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity. Psychiatry Res 96:51-61.
57. Qu Y, Villacreses N, Murphy DL, Rapoport SI (2005) 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology (Berl) 180:12-20.
58. Rattray M, Baldessari S, Gobbi M, Mennini T, Samanin R, Bendotti C (1996) p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product. J Neurochem 67:463- 472.
59. 11C]DASB is affected by serotonin transporter genotype. J Neural Transm 114:635- 639.
60. Riad M, Rbah L, Verdurand M, Aznavour N, Zimmer L, Descarries L (2008) Unchanged density of 5-HT(1A) autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine. Neuroscience 151:692-700.
61. Rioux A, Fabre V, Lesch KP, Moessner R, Murphy DL, Lanfumey L, Hamon M, Martres MP (1999) Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter. Neurosci Lett 262:113-116.
62. Rossi DV, Burke TF, McCasland M, Hensler JG (2008) Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline. J Neurochem 105:1091-1099.
63. Rothman RB, Jayanthi S, Wang X, Dersch CM, Cadet JL, Prisinzano T, Rice KC, Baumann MH (2003) High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse 50:233-239.
64. Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F (2004) Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14:1100 -1109.
65. Sharp T, Boothman L, Raley J, Quérée P (2007) Important messages in the "post": recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci 28:629-636.
66. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87-97.
67. 3H]LSD) binding in healthy volunteers. Psychopharmacology (Berl) 133:39-42.
68. Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, HaugbØl S, FrØkjaer VG, Holm S, Paulson OB, Knudsen GM (2005) MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 24:969 -979.
69. 11C-DASBin healthy humans. Synapse 55:164-175.
70. 123I]beta-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry 161:525-531.
71. Varnäs K, Halldin C, Hall H (2004) Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 22:246 -260.
72. Wood SN (2008) Fast stable direct fitting and smoothness selection for generalized additive models. J R Stat Soc B 70:495-518.
73. Zhou FC, Tao-Cheng JH, Segu L, Patel T, Wang Y (1998) Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence. Brain Res 805:241-254.
74. Zhou FC, Sari Y, Zhang JK (2000) Expression of serotonin transporter protein in developing rat brain. Brain Res Dev Brain Res 119:33- 45.